79 related articles for article (PubMed ID: 90095)
1. Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse.
Yamauchi K; Fujimoto S; Tada T
J Immunol; 1979 Oct; 123(4):1653-8. PubMed ID: 90095
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells.
Greene MI; Perry LL
J Immunol; 1978 Dec; 121(6):2363-6. PubMed ID: 82582
[TBL] [Abstract][Full Text] [Related]
3. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
4. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma.
Haubeck HD; Kölsch E
J Immunol; 1985 Dec; 135(6):4297-302. PubMed ID: 2415609
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
[TBL] [Abstract][Full Text] [Related]
8. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
Owens T; Crispe IN
J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
10. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
11. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
Koyama S; Yoshioka T; Sakita T
Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
[TBL] [Abstract][Full Text] [Related]
13. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
Braley-Mullen H
J Immunol; 1983 Nov; 131(5):2190-5. PubMed ID: 6195257
[TBL] [Abstract][Full Text] [Related]
14. Suppressor cell clones specific for ultraviolet radiation-induced tumors. Function and surface proteins.
Trial J; McIntyre BW
J Immunol; 1990 Oct; 145(7):2044-9. PubMed ID: 1975821
[TBL] [Abstract][Full Text] [Related]
15. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
Brondz BD; Kahn ES; Chervonsky AV; Isakova VR; Apasov SG; Blandova ZK
Exp Clin Immunogenet; 1987; 4(4):211-21. PubMed ID: 2978841
[TBL] [Abstract][Full Text] [Related]
16. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
17. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
18. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
Gautam SC; Deodhar SD
Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
[TBL] [Abstract][Full Text] [Related]
19. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
